Consolidated Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Assets
Cash	$ 1,424,426	$ 3,378,152
Digital assets - current (Note 4)	2,563,474	9,021,927
Finance receivables	17,533	21,051
Marketable securities (Note 7)	37,380	27,050
Receivable from sale of Symbiont assets (Note 7)	0	200,000
Prepaid expenses and other assets	1,198,486	827,237
Digital assets - collateral (Note 4)	5,500,000	0
Digital assets receivable, net (Note 4)	12,678,014	0
Galaxy loan derivative (Note 8)	47,673	0
Income tax receivable	31,187	31,187
Current assets	23,498,173	13,506,604
Fixed assets, net (Note 5)	9,917,350	18,376,948
Intangible assets, net (Note 5)	6,327,769	5,478,958
Deposit on mining equipment (Note 6)	1,597	467,172
Long-term investments - equity securities (Note 7)	233	4,255
Investment in Seastar Medical Holding Corporation (Note 7)	$ 24,840	$ 200,790
Investment, Issuer Affiliation [Extensible Enumeration]	us-gaap:InvestmentAffiliatedIssuerMember	us-gaap:InvestmentAffiliatedIssuerMember
Digital assets - long-term (Note 4)	$ 8,233,035	$ 0
Digital assets - collateral (Note 4)	2,200,000	5,000,000
Right of use assets (Note 9)	728,995	938,641
Other assets	384,234	73,857
Long-term assets	27,818,053	30,540,621
Total assets	51,316,226	44,047,225
Liabilities and stockholders' equity
Accounts payable and accrued expenses	1,745,875	989,563
Note payable - short-term (Note 8)	7,006,912	386,312
Master digital currency loan (Note 8)	10,920,838	0
Due to related parties (Note 11)	$ 48,319	$ 15,944
Other Liability, Current, Related Party [Extensible Enumeration]	Related Party [Member]	Related Party [Member]
Current portion of lease liability (Note 9)	$ 194,618	$ 170,967
Total current liabilities	19,916,562	1,562,786
Note payable - long-term (Note 8)	1,932,502	6,365,345
Lease liability - net of current portion (Note 9)	590,368	776,535
Long-term liabilities	2,522,870	7,141,880
Total liabilities	22,439,432	8,704,666
Stockholders' equity (Note 12)
Preferred stock, par value $.001; 150,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and December 31, 2024
Common stock, par value $.001; 350,000,000 shares authorized; 14,123,497 and 5,133,412 shares issued and outstanding as of December 31, 2025 and December 31, 2024	13,592	4,602
Additional paid-in capital	123,186,921	102,685,470
Accumulated deficit	(92,582,928)	(65,662,731)
Total LM Funding America stockholders' equity	30,617,585	37,027,341
Non-controlling interest	(1,740,791)	(1,684,782)
Total stockholders' equity	28,876,794	35,342,559
Total liabilities and stockholders’ equity	$ 51,316,226	$ 44,047,225

LM FUNDING AMERICA, INC. 10-K